0001161697-23-000610.txt : 20231212 0001161697-23-000610.hdr.sgml : 20231212 20231212170041 ACCESSION NUMBER: 0001161697-23-000610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231208 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANDE ALICIA CENTRAL INDEX KEY: 0001402652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 231481897 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 12-08-2023 X0508 4 2023-12-08 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402652 GRANDE ALICIA 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 VP, Treasurer and CFO 0 Common stock, par value $0.001 per share 2023-12-08 4 M 0 40000 1.13 A 90557 D Common Stock, par value $0.001 per share 2023-12-08 4 S 0 20000 14.25 D 70557 D Common Stock, par value $0.001 per share 2023-12-08 4 S 0 20000 14.30 D 50557 D Common Stock, par value $0.001 per share 2023-12-11 4 M 0 60000 1.13 A 110557 D Common Stock, par value $0.001 per share 2023-12-11 4 S 0 30000 13.74 D 80557 D Common Stock, par value $0.001 per share 2023-12-11 4 S 0 30000 13.786 D 50557 D Options to purchase common stock 1.13 2023-12-08 4 M 0 40000 0 D 2024-01-03 Common Stock 40000 1255834 D Options to purchase common stock 1.13 2023-12-11 4 M 0 60000 0 D 2024-01-03 Common Stock 60000 1195834 D Ms. Grande sold the shares on the open market, for personal reasons, and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.74 to $13.745 per share. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.78 to $13.79 per share. Options vested in three annual tranches beginning on January 3, 2018. /s/ Alicia Grande 2023-12-12